PRM162 Appropriate Comparative Treatments for Early Benefit Assessment (EBA) in Germany. Comparing the Suggestions by the Joint Federal Committee (GBA) and the Pharmaceutical Companies
Abstract
Authors
J. Ruof J. Scherer J.M. Schulenburg